VIMTA LABS
|
The Current P/S Ratio of VIMTA LABS is 3.77.
Share Price | ₹543.7 | Apr 29,2024 |
Market Cap | ₹1,207.0 Cr | |
Sales-TTM | ₹320.4 Cr | TTM-Consolidated Results |
Price/Sales | 3.77x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of VIMTA LABS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹1,207.0 Cr] as on Apr 29,2024
(/) Sales [ ₹320.4 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 3.77x ]
Thus, for VIMTA LABS , the investors are currently willing to pay '3.77 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of VIMTA LABS !
The chart below summarizes the trend in P/S Ratio of VIMTA LABS over the last five years.
Historical PS (Price/Sales) ratio chart of VIMTA LABS
PS Ratio Performance Analysis for VIMTA LABS
- VIMTA LABS 's p/e ratio for fiscal years ending Mar2023 to Mar2020 averaged 1.78x.
- VIMTA LABS 's operated at median p/e ratio of 2.19x from fiscal years ending March 2018 to 2022.
- Looking back at the last 4 fiscal years, VIMTA LABS 's p/e ratio peaked in Mar2022 at 2.5x.
- VIMTA LABS 's p/e ratio hit its five-year low in Mar2020 of 0.72x.
How does VIMTA LABS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
VIMTA LABS | 320.4 | 3.77 | 1,207.0 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 47,444.6 | 7.70 | 365,167.0 |
CIPLA LTD | 25,350.2 | 4.48 | 113,645.0 |
DR REDDYS LABORATORIES LTD | 27,212.5 | 3.86 | 104,987.0 |
ZYDUS LIFESCIENCES LTD | 19,024.2 | 5.10 | 96,950.6 |
DIVIS LABORATORIES LTD | 7,492.8 | 14.13 | 105,890.0 |
MANKIND PHARMA LTD | 9,946.3 | 9.60 | 95,492.3 |
TORRENT PHARMACEUTICALS LTD | 10,474.0 | 8.69 | 90,980.9 |
LUPIN LTD | 19,480.1 | 3.83 | 74,631.4 |
AUROBINDO PHARMA LTD | 27,894.7 | 2.42 | 67,488.4 |
ABBOTT INDIA LTD | 5,753.4 | 9.71 | 55,838.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs VIMTA LABS 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.42x |
Max industry PS | 14.13x |
Median industry PS | 5.10x |
Average industry PS | 6.66x |
You may also like the below Video Courses